Managing MRSA, MRSP, and MRSS dermatologic infections in pets - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


Managing MRSA, MRSP, and MRSS dermatologic infections in pets
Has one of these resistant infections invaded one of your patients? What should you do now to eliminate the infection? Read on...



1. Frank LA, Loeffler A. Meticillin-resistant Staphylococcus pseudintermedius: clinical challenge and treatment options. Vet Dermatol 2012; 23(4):283-291.

2. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care–associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290(22):2976-2984.

3. Manian F. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contact. Clin Infect Dis 2003;36(2):e26-28.

4. Faires MC, Traverse M, Tater K, et al. Methicillin-resistant and –susceptible Staphylococcus aureus infections in dogs. Emerg Infect Dis 2010;16(1): 69-75.

5. Bryan J, Frank L, Rohrbach BW, et al. Treatment outcome of dogs with methicillin-resistant and methicillin-susceptible Staphylococcus pseudintermedius pyoderma. Vet Dermatol 2012;23(4):361-368.

6. Ridenour G, Lampen R, Federspiel J, et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28(10):1155-1161.

7. Griffeth GC, Morris DO, Abraham JL, et al. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol 2008;19(3):142-149.

8. Saijonmaa-Koulumies L, Parsons E, Lloyd DH. Elimination of Staphylococcus intermedius in healthy dogs by topical treatment with fusidic acid. J Small Anim Pract 1998;39(7):341-347.

9. Young, R, Buckley L, McEwan N, et al. Comparative in vitro efficacy of antimicrobial shampoos: a pilot study. Vet Dermatol 2012;23(1):36-40.

10. Bemis DA, Jones RD, Frank LA, et al. Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest 2009;21(1):53-58.

11. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005;40(4):562-573.

12. Dalhoff A, Schubert S. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones. Int J Antimicrob Agents 2010;36(3):216-221.

13. Venezia RA, Domaracki BE, Evans AM, et al. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolones exposure. J Antimicrob Chemother 2001;48(3):375-381.

14. Papich MG, Riviere JE. Fluoroquinolone antimicrobial drugs. In: Riviere JE, Papich MG, eds. Veterinary pharmacology and therapeutics, 9th ed. Ames, Iowa: Wiley-Blackwell Publishing, 2009.

15. Aucoin DP. Baytril: historical impact and milestones of veterinary medicine's most successful antimicrobial, in Proceedings. Fourth Intl Baytril Symp, 2009;6-15.

16. Papich MG. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs. Am J Vet Res 2012;73(7):1085-1091.

17. Papich MG. Selection of antibiotics for meticillin-resistant Staphylococcus pseudintermedius: time to revisit some old drugs? Vet Dermatol 2012;23(4):352-360.

18. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356(9238):1307-1312.

19. Anderson ME, Lefebvre SL, Weese JS. Evaluation of prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in veterinary personnel attending an international equine veterinary conference. Vet Microbiol 2008;129(3-4):410-417.

20. Weese JS. Staphylococcal control in the veterinary hospital. Vet Dermatol 2012;23(4):292-298.

21. Kramer A, Schwebke L, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:130.

22. Laarhoven LM, de Heus P, van Luijn J, et al. Longitudinal study on methicillin-resistant Staphylococcus pseudintermedius in households. PLoS One 2011;6(11):e277788.

23. Loeffler A, Pfeiffer DU, Lindsay JA, et al. Lack of transmission of methicillin-resistant Staphylococcus aureus (MRSA) between apparently healthy dogs in a rescue kennel. Vet Microbiol 2010;141(1-2):178-181.


Click here